Investigating cortico-striatal beta oscillations in Parkinson's disease cognitive decline.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

1. Buspirone regulates cortico-striatal gamma oscillations to ameliorate dyskinesia.Journal of Parkinson's disease · 2025
   Article
2. Personalized temporal interference stimulation targeting striatum reduces functional stability and dynamic connectivity variability in the sensorimotor network.Frontiers in neuroscience · 2025
   Article
3. Hypo-connectivity of the primary somatosensory cortex in Parkinson's disease: a resting-state functional MRI study.Frontiers in neurology · 2024
   Article
4. Mild cognitive impairment in Parkinson's disease: current view.Frontiers in cognition · 2024
   Review
5. Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks.International journal of molecular sciences · 2023
   Review

Corrections and comments

• Comment on
  Corticostriatal beta oscillation changes associated with cognitive function in Parkinson's disease.2023

Authors and funding

2 authors at 1 institution in 1 country.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as